Haemonetics announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A.

Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued ...

In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics (HAE – Research Report). The company’s shares ...

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the ...

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma ...

In a report released on January 6, Michael Petusky from Barrington maintained a Buy rating on Haemonetics (HAE – Research Report), with a price ...

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite ...

Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Abbott (ABT). But which of these two stocks offers value investors a better ...

Central Pacific Bank Trust Division lowered its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 10.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The ...

along with Haemonetics' manufacturing facility in Covina, California where certain of these products are produced, and related equipment and assets located at Haemonetics' manufacturing facility ...

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has completed the ...